In Summary
- A common reason Korean herbal medicine and acupuncture fail to produce expected results is not treatment selection but patient expectation: the pharmaceutical model of rapid, symptom-targeted response does not map onto constitutional medicine that works through gradual systemic recalibration.
- Discontinuing treatment at the first sign of improvement — before the constitutional shift has consolidated — is a frequent source of relapse in otherwise well-responding patients.
- Some patients experience a transient worsening of symptoms in the early phase of treatment; this needs to be carefully distinguished by the treating practitioner from a genuine adverse reaction, which requires stopping and reassessment.
- The therapeutic relationship in Korean medicine differs from the specialist consultation model: it relies on ongoing constitutional assessment that cannot be replaced by standardized protocols or self-directed supplement use.
Over many years of clinical practice, the question I am asked most frequently by patients who have had unsatisfying experiences with Korean herbal medicine or acupuncture is some variant of the same question: why didn’t it work? I want to address this honestly, because the answer is clinically important and rarely given with sufficient clarity.
Sometimes the answer is that the treatment was not well-matched to the patient’s pattern. But more often, the answer involves one of several predictable mismatches between how constitutional medicine works and what patients, shaped by the pharmaceutical model, expect it to do.
The Expectation Gap
Modern patients are accustomed to medicines that produce rapid, measurable, symptom-targeted effects. An antibiotic clears a bacterial infection within days. An antihypertensive lowers blood pressure within hours. A pain medication produces relief within the pharmacokinetic window of the drug. The mental model of medicine as a specific intervention producing a specific, rapid response is so deeply embedded that most patients apply it unconsciously to every treatment they try — including constitutional medicine, where it fits poorly.
Korean herbal medicine and acupuncture are understood to work through recalibration of the body’s regulatory systems. A tonifying herbal formula does not add Qi in the way that a glucose infusion adds calories — the model is that it provides biochemical signals and substrates that support the body’s own Qi-generating processes over time. Acupuncture is thought to act not by directly suppressing inflammation but by modulating the autonomic and neuroendocrine systems that regulate the inflammatory response, an effect that, where it occurs, tends to develop over a course of treatment rather than a single session.
The clinical consequence of this mismatched expectation is premature discontinuation. A patient who begins a constitutional herbal course for chronic fatigue and reports no significant change after two weeks has often not yet given the treatment adequate time. A patient who stops acupuncture after three sessions because they don’t feel better has withdrawn before any cumulative effect could accumulate. In my clinical experience, constitutional herbal treatment typically requires four to eight weeks before the patient can assess its direction reliably, and acupuncture for chronic conditions often requires six to twelve sessions before any effect consolidates.
Stopping Too Soon After Improvement
The opposite error — stopping treatment at the first sign of improvement — is equally common and equally counterproductive. A patient whose chronic digestive symptoms have improved significantly after six weeks of herbal treatment discontinues the formula because they feel better. Within four to six weeks, the symptoms return, and the patient concludes that the treatment only worked temporarily.
What often happened is that the treatment produced a functional improvement before the underlying constitutional shift consolidated. The digestive system is functioning better, but the constitutional pattern that produced the dysfunction has not yet changed sufficiently to maintain the improvement without continued support. Discontinuing the formula at this point is like removing scaffolding from a structure that is nearly but not fully self-supporting — the structure can stand briefly and then gradually resumes its former shape.
The consolidation phase — continuing treatment through the period of improvement until the constitutional shift becomes self-sustaining — is, in this framework, as important as the initial treatment phase. Patients who understand this and maintain treatment through consolidation, under their practitioner’s guidance, tend to have better long-term outcomes than those who stop at symptomatic improvement.
The Initial Worsening Phenomenon — and an Important Safety Boundary
Some patients experience a transient worsening of symptoms in the early phase of constitutional treatment, and this understandably produces anxiety. The traditional reading is that when the body has been maintaining a chronic compensatory pattern, beginning treatment that targets the underlying imbalance can temporarily disturb that arrangement before the root pattern is sufficiently corrected — a body in transition between two equilibrium states rather than a reaction against the treatment.
That reading is sometimes correct. But it is also the single most dangerous idea in this whole discussion if it is misapplied, because it can be used to rationalize pushing through what is actually a genuine adverse reaction. So I want to be very clear about the boundary, and about who gets to make the call.
This distinction is not for the patient to make alone. Any worsening during treatment should be reported promptly to the prescribing practitioner, who can assess it in the context of the whole picture. As a rough guide, a benign transitional response tends to be mild, peaks within roughly one to two weeks, is accompanied by other signs of physiological movement (shifts in sleep, digestion, energy, or mood), and eases as treatment continues. By contrast, certain things are never to be “pushed through” and call for stopping the herbs and seeking medical care without delay: any sign of an allergic reaction (rash, hives, facial or throat swelling, difficulty breathing); severe, escalating, or systemic symptoms; yellowing of the skin or eyes, dark urine, or right-upper-abdominal pain (possible liver injury); or any symptom that frightens you. When in doubt, stop and ask — a true transitional response loses nothing by being paused for assessment, whereas a genuine adverse reaction can be made worse by continuing.
The Self-Treatment Problem
A growing proportion of patients who report disappointing results with Korean medicine have not actually received individualized Korean medicine — they have self-selected commercial herbal supplements based on general health marketing and applied them without constitutional assessment. The results, predictably, are inconsistent: some patients with constitutions that match the formula’s target happen to benefit; others, whose constitutions do not match, do not, and some experience side effects.
Constitutional pattern differentiation is not optional in Korean herbal medicine. A blood-tonifying formula given to a patient whose primary pattern is Qi stagnation with heat will not produce blood-tonifying effects — it may produce heat accumulation instead. The same formula that is clinically appropriate for one patient may be inappropriate for another with apparently similar symptoms but a different constitutional pattern.
This is why the therapeutic relationship in Korean medicine is best understood not as a prescription-dispensing service but as an ongoing constitutional assessment. The practitioner who sees the same patient over months and years is tracking the evolution of the constitutional pattern, adjusting formulas as the pattern shifts, watching for interactions with any conventional medications the patient takes, and responding to feedback in ways that no standardized protocol or supplement label can replicate.
This article reflects the clinical observations and teaching practice of Professor Seungho Baek, Professor of Korean Medicine at Dongguk University College of Korean Medicine, specializing in Pathology and Oncology.